ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Basic Aromatherapy to Help Balance and Calm

Tea drinkers have lower glaucoma risk

Soy, cruciferous vegetables could help lower breast cancer treatment side effects

The Long-Term Benefits of Drinking Oolong Tea

Why You Should Try This Sweet-Smelling and Health-Boosting Essential Oil

Wonderful White Tea: A Drink Fit for an Emperor

Arnica: This Powerful Herb Promotes Various Kinds of Healing

Chamomile Tea: Why This Ancient Therapeutic Drink Still Stands Out Today

Get ‘Hooked’ on Cat’s Claw: The Many Benefits of This Amazonian Herb

Try Apple Cider Vinegar and Black Cumin Oil as Your Go-To Salad Dressing

Print Page
Email Article

Symposium Charts Progress and Explores New Paths

  [ 15 votes ]   [ Discuss This Article ]
By Vicki C. Walker and Renee M. Brehio • • February 14, 2002

The following article is reprinted with permission from The CFS Research Review Vol. 2 No. 1 Winter, 2001.

In December 2000, researchers convened for two days of intense discussions on orthostatic intolerance (OI) in chronic fatigue syndrome (CFS), exploring the evidence for autonomic nervous system dysfunction, outlining the limits of current knowledge, and seeking to improve and accelerate future research.

The meeting was organized as a “scientific court,” a format used by the National Institutes of Health (NIH) to develop consensus statements on scientific issues, including research priorities for Gulf War illnesses.

Following a full day of presentations by recognized experts, an independent panel representing the fields of endocrinology, epidemiology, pediatrics, rheumatology, neurology, psychology, allergy, and internal medicine, as well as two CFS patients, developed a consensus statement on five key questions about CFS and OI.

Key findings of the panel included:

There is evidence of an altered autonomic nervous system (ANS) and/or circulatory system in CFS patients.

The panel noted that the symptoms of OI are often seen in CFS patients and that the physiological stressors that exacerbate OI may also intensify symptoms in CFS patients.

The exact relationship between OI and CFS is unclear.

Although both may be preceded by a viral-like illness, patients with OI but not CFS often do not report the characteristic symptoms of CFS, including severe fatigue, postexertional malaise, joint and muscle pain, recurrent sore throat, and painful lymph nodes.

Methods for studying ANS dysfunction in CFS are available.

Although a number of conditions such as OI, Addison’s disease, and acute Epstein-Barr infection have clinical features in common with CFS, there are no human research models that sufficiently reflect the spectrum of CFS symptoms.

However, the panel pointed out that animal models and tests measuring a patient’s response to a specific activity or pharmacologic challenge can be used to study aspects of autonomic regulation in CFS.

There are relationships between ANS dysfunction and other abnormalities seen in CFS patients.

Data suggest that CFS patients have altered relationships among the ANS and the cardiovascular, neuroendocrine, and immune systems. The panel recognized that the extensive interdependence of these systems makes discovery of the primary cause of CFS a challenge for the research community.

More research is needed to further define the possible interaction between OI and CFS.

The panel outlined future research needs, including more studies of autonomic function and altered brain perfusion, examination of the relationships between the ANS and other body systems, and testing of therapeutic interventions to directly impact patient care in CFS.

The panel also suggested ways to overcome some of the methodological barriers researchers have faced, including subgrouping CFS patients to handle the heterogeneity of the patient base and creating standard definitions of OI terms to ensure that future study results can be compared against one another.

The scientific court on OI in CFS was organized by The CFIDS Association of America, which supports and facilitates research seeking to uncover the mechanisms and potential cause of CFS. This was the first meeting in a symposia series to explore and assess in-depth key questions facing CFS researchers.

The symposia are designed to identify the most promising net steps for research; define research and funding priorities; provide scientific evaluation of current research findings; use the synergy of exchange to identify possible links, mechanisms, and causalities; and foster research collaboration teams.

Future Association research symposia topics will include neuroendocrinology, immunology, and diagnostic methodologies.

The panel’s consensus statement has been submitted to a peer-reviewed scientific publication to communicate the stimulating findings and opportunities in CFS research, and to encourage researchers to bring their knowledge and interests to bear on this area.

To preserve the ability to publish the statement in the medical literature, the complete statement is not yet available for distribution.

Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Ultra EPA  - Fish Oil Energy NADH™ 12.5mg

Article Comments

Be the first to comment on this article!

Post a Comment

Optimized Curcumin Longvida with Omega-3

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get Energized with Malic Acid & Magnesium
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

The New Dual Activation Pain Relief Cream The New Dual Activation Pain Relief Cream
Block food Cravings At Their Molecular Root Block food Cravings At Their Molecular Root
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS
Prepare Yourself for Cold & Flu Season Prepare Yourself for Cold & Flu Season
Health Benefits Are Brewing in Green Tea Health Benefits Are Brewing in Green Tea

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map